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ABSTRACT We investigated the contribution of the carboxyl terminus region of the b1a subunit of the skeletal dihydropyridine
receptor (DHPR) to the mechanism of excitation-contraction (EC) coupling. cDNA-transfected b1 KO myotubes were voltage
clamped, and Ca2þ transients were analyzed by confocal ﬂuo-4 ﬂuorescence. A chimera with an amino terminus half of b2a and
a carboxyl terminus half of b1a (b2a 1-287 / b1a 325-524) recapitulates skeletal-type EC coupling quantitatively and was used
to generate truncated variants lacking 7 to 60 residues from the b1a-speciﬁc carboxyl terminus (D7, D21, D29, D35, and D60).
Ca2þ transients recovered by the control chimera have a sigmoidal Ca2þ ﬂuorescence (DF/F) versus voltage curve with
saturation at potentials more positive than þ30 mV, independent of external Ca2þ and stimulus duration. In contrast, the
amplitude of Ca2þ transients expressed by the truncated variants varied with the duration of the pulse, and for D29, D35, and
D60, also varied with external Ca2þ concentration. For D7 and D21, a 50-ms depolarization produced a sigmoidal DF/F versus
voltage curve with a lower than control maximum ﬂuorescence. Moreover, for D29, D35, and D60, a 200-ms depolarization
increased the maximum ﬂuorescence and changed the shape of the DF/F versus voltage curve, from sigmoidal to bell-shaped,
with a maximum at ;þ30 mV. The change in voltage dependence, together with the external Ca2þ dependence and additional
controls with ryanodine, indicated a loss of skeletal-type EC coupling and the emergence of an EC coupling component
triggered by the Ca2þ current. Analyses of d(DF/F)/dt showed that the rate of cytosolic Ca2þ increase during the Ca2þ transient
was ﬁvefold faster for the control chimera than for the severely truncated variants (D29, D35, and D60) and was consistent with
the kinetics of the DHPR Ca2þ current. In summary, absence of the b1a-speciﬁc carboxyl terminus (last 29 to 60 residues of the
control chimera) results in a loss of the fast component of the Ca2þ transient, bending of the DF/F versus voltage curve, and
emergence of EC coupling triggered by the Ca2þ current. The studies underscore the essential role of the carboxyl terminus
region of the DHPR b1a subunit in fast voltage dependent EC coupling in skeletal myotubes.
INTRODUCTION
The dihydropyridine receptor (DHPR) a1 and b subunits are
both essential for Ca2þ channel formation and for triggering
excitation-contraction (EC) coupling in skeletal muscle
(Tanabe et al., 1988; Gregg et al., 1996). The a1 subunit
forms the Ca2þ pore and houses the electrical charges that
sense the membrane voltage. a1 belongs to the superfamily
of voltage-gated channel proteins with four internal repeats,
each composed of six transmembrane segments. The S4
segments form part of a voltage sensor that moves outward in
response to membrane depolarization, and this movement is
coupled to the opening of the pore (Bezanilla, 2000). b
subunits are ;60 kDa proteins that bind strongly to the
cytosolic loop between repeats I and II of a1 via a conserved
;30-residue b interaction domain (BID) (Pragnell et al.,
1994; De Waard et al., 1994). They are structurally related
to the membrane-associated guanylate kinase (MAGUK)
superfamily of proteins, commonly engaged in membrane
signaling (Hanlon et al., 1999). Studies in heterologous cells
have shown that b subunits are vital for trafﬁcking the newly
synthesized DHPR to the cell surface (Chien et al., 1995;
Neuhuber et al., 1998). A mechanism has been proposed
where b, by binding to the I-II loop of a1, relieves the
inhibitory signal that retains a1 in the endoplasmic reticulum
(Bichet et al., 2000). Various b subunits modulate the
kinetics of activation and inactivation of the Ca2þ current
produced by cardiac and brain pore isoforms (Olcese et al.,
1994; Qin et al., 1996; Wei et al., 2000; Berrou et al., 2001)
and strengthen the coupling between S4 charge movements
and pore opening (Neely et al., 1993; Olcese et al., 1996;
Kamp et al., 1996). Furthermore, the skeletal muscle speciﬁc
b1a subunit (Powers et al., 1992) is required for triggering
Ca2þ transients in skeletal muscle (Beurg et al., 1999a),
suggesting a role in coupling charge movements to the
opening of ryanodine receptor type 1 (RyR1).
In skeletal muscle, charge movements in the DHPR are
responsible for activation of RyR1. Yet the Ca2þ current,
also activated by the charge movements, is not essential for
EC coupling function (Dirksen and Beam, 1999; Ahern
et al., 2001a). This signaling mechanism is known as voltage-
dependent, or skeletal-type, EC coupling. Its ﬁngerprint
characteristics are a sigmoidal relationship between the
amplitude of the Ca2þ transient and the magnitude of the
depolarization and a saturation of the Ca2þ transient
amplitude at large positive potentials (Garcia et al., 1994;
Ahern et al., 2001b). In cardiac muscle, the Ca2þ current
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through the DHPR L-type Ca2þ channel must diffuse to the
sarcoplasmic reticulum (SR) to trigger the opening of RyR2.
This mechanism is referred to as Ca2þ-dependent EC
coupling and its main characteristic is a biphasic, bell-shaped
relationship between the amplitude of the Ca2þ transient
and the magnitude of the depolarization, such that the
Ca2þ transient is always proportional to the Ca2þ current
(Beuckelmann and Wier, 1988). A change from purely
voltage-dependent EC coupling to Ca2þ-dependent EC
coupling has been described in skeletal dysgenic (a1S-null)
myotubes expressing a1C, the cardiac pore isoform, instead
of a1S, the endogenous isoform (Tanabe et al., 1990a). This
and other related studies (Tanabe et al., 1990b; Garcia et al.,
1994) showed that a1S specializes in voltage dependent EC
coupling whereas a1C is involved in Ca2þ dependent EC
coupling. The a1 isoform alone would thus appear to dictate
the intrinsic characteristics of the EC coupling process, at
least in the cellular context of the dysgenic myotube.
Sequence comparison between b1a, the major isoform of
skeletal muscle, and b2a, primarily expressed in the brain
and heart, revealed two conserved central regions amounting
to more than half of the total peptide sequence (domains D2
and D4), a nonconserved linker between the two conserved
domains (D3), a nonconserved amino terminus (D1), and
a nonconserved carboxyl terminus (D5) (Perez-Reyes and
Schneider, 1994). We previously tested the participation of
D1, D3, and D5 of b1a in the recovery of Ca2þ conductance,
charge movements, and EC coupling in b1 KO skeletal
myotubes (Beurg et al., 1999b). Deletion of D5 (b1a
residues 470-524) drastically reduced the amplitude of
voltage-evoked Ca2þ transients without affecting the density
of charge movements. Thus the membrane density of DHPR
voltage sensors, critical for voltage dependent EC coupling,
was not compromised by the carboxyl terminal deletion. On
the basis of this result, we implicated D5 in skeletal-type EC
coupling. The identiﬁcation of D5 was also important
because it showed that domains of b1a that participate in
EC coupling differ from the BID domain present in the D4
region (b1a residues 250-300). Hence it is clear that in the b
subunit, the trafﬁcking function controlled by the BID
domain (Chien et al., 1995; Bichet et al., 2000), and the EC
coupling function have different molecular underpinnings.
In the present study, we further investigated the EC
coupling function of D5 in chimeras of b1a and b2a and
truncated variants, all having demonstrably intact BID/I-II
loop interactions. We show that small truncations of the
carboxyl terminus of b1a produce drastic changes in EC
coupling, altering it from a purely voltage dependent process
to one controlled by voltage and the Ca2þ current. The
changes are functionally equivalent to those observed in
dysgenic myotubes expressing a1C and are consistent with
a view in which the DHPR b subunit, like a1S, is a key
structural determinant of skeletal-type EC coupling. Part of
this work has been previously published in abstract form
(Sheridan et al., 2002a).
MATERIALS AND METHODS
Primary cultures
Cultures of myotubes were prepared from hind limbs of E18 fetuses as
described previously (Beurg et al., 1997). Muscles dissected from the fetuses
were treated with 0.125% (w/v) trypsin and 0.05% (w/v) pancreatin. After
centrifugation, mononucleated cells were resuspended in plating medium
containing 78% Dulbeccos’s modiﬁed Eagle’s medium with low glucose,
10% horse serum, 10% fetal bovine serum, and 2% chicken serum extract.
Cells were plated on plastic culture dishes coated with gelatin at a density of
;1 3 104 cells per dish. Cultures were grown at 378C in 8% CO2 gas. After
myoblast fusion (;6 days), the medium was replaced with fetal bovine
serum free medium and CO2 was decreased to 5%.
cDNA transfection
All cDNAs were cloned into the mammalian expression vector pSG5
(Stratagene, La Jolla, CA). cDNA transfection was performed during the
myoblast fusion stage with the polyamine LT1 (Panvera, Madison, WI).
Cells were exposed for 2–3 h to a transfection solution containing LT1 and
cDNA at a 5:1 mg ratio. In addition to the cDNA of interest, cells were
cotransfected with a plasmid encoding the T-cell protein CD8 used here as a
transfection marker. Transfected myotubes expressing CD8 were recognized
by surface binding of polystyrene beads coated with a monoclonal antibody
speciﬁc for an external CD8 epitope (Dynal ASA, Norway). The efﬁciency
of cotransfection of the marker and the cDNA of interest was;90%. Whole-
cell analysis of Ca2þ currents and Ca2þ transients was performed 3–5 days
after transfection.
cDNA constructs
Deletion and chimeric variants were made by polymerase chain reaction
(PCR) strategies using cDNAs for mouse b1a (residues 1-524; Genbank
accession # NM_031173) and rat b2a (residues 1-604; Genbank accession #
M80545). The PCR products were subcloned into the pCR-Blunt vector
(Invitrogen Inc., Carlsbad, CA), excised by digestion with AgeI and NotI
and cloned into the pSG5 vector in frame with the ﬁrst 11 residues of the
phage T7 gene 10 protein for antibody tagging. All constructs were
sequenced twice or more at a campus facility.
b2-b1
This cDNA contains residues 1-287 of b2a fused to the amino terminus of
residues 325-524 of b1a and was made by two rounds of PCR as described
previously (Beurg et al., 1999b).
b2-b1 D7
This cDNA contains residues 1-287 of b2a fused to the amino terminus of
residues 325-517 of b1a and was made by PCR using the chimeric b2-b1
cDNA as template. Two primers were used to PCR the 39 end of the b1a
cDNA with the last seven amino acids deleted, B1MluI (59-tcc aac acg cgt
tcc agc ctg gc-39) and B1D7 (59-tta ggc cac cgc gtc gcc tcc ccg-39). The PCR
product was subcloned into pCR2.1 vector (Invitrogen), excised with MluI
and NotI, puriﬁed from the gel using QIAquick gel extraction kit (Qiagen,
Valencia, CA) and ligated into the pSG5-T7-b2-b1 chimera via unique
MluI and NotI sites. Except for primers, all deletion constructs below were
generated by the same strategy.
b2-b1 D21
This cDNA contains residues 1-287 of b2a fused to the amino terminus of
residues 325-503 of b1a. Primers to PCR the 39 end of the b1a cDNA with
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the last 21 amino acids deleted were B1MluI (above) and B1D21 (59-cta cca
gaa gct gag att tct cct gag-39).
b2-b1 D29
This cDNA contains residues 1-287 of b2a fused to the amino terminus of
residues 325-495 of b1a. Primers to PCR the 39 end of the b1a cDNA with
the last 29 amino acids deleted were B1MluI (above) and B1D29 (59-tta cga
ggt gag cac ctg tac ctg g-39).
b2-b1 D35
This cDNA contains residues 1-287 of b2a fused to the amino terminus of
residues 325-489 of b1a. Primers to PCR the 39 end of the b1a cDNA with
the last 35 amino acids deleted were B1MluI (above) and B1D35 (59-tat gcg
gcc gct tac tgg agg ttg gag acg gg-39).
b2-b1 D60
This cDNA contains residues 1-287 of b2a fused to the amino terminus of
residues 325-464 of b1a cDNA and was made as described previously
(Beurg et al., 1999b).
b1aD278-287
This construct was generated by two steps of PCR and subcloned into the
pSG5-T7-tagged expression vector using XhoI and MluI sites. The cDNA
encoding b1a residues 1-277 was ampliﬁed by S1 primer 59-gtt ata gga tcc
atg gtc cag aag agc ggc-39 and RBID primer 59-ctg tca cct cga tgg gcc tca tgg
aagg-39. The cDNA encoding b1a residues 288-300 was ampliﬁed by FBID
primer 59-agg ccc atc gag gtg aca gac atg atg-39 and RMluI primer 59-agc
cag gct gga acg cgt gtt gga g-39. The two PCR products were puriﬁed on
QIAquick PCR puriﬁcation columns (Qiagen), diluted and mixed at a 1:1
weight ratio, and used for a second PCR at 958C for 1 min, 438C for 1 min,
and 728C for 1 min for ﬁve cycles. Thereafter, primers S1 and RMluI were
added to the mixture and the PCR was continued for additional 30 cycles.
The ampliﬁed PCR product was subcloned into a pCR 2.1 vector, cut with
XhoI and MluI, and subcloned into a XhoI/MluI digested pSG5-T7-b1a
construct.
a1C (CaV1.2)
A full-length rabbit a1C cDNA encoding residues 1-2171 (Genbank
accession # X15539, nucleotide coordinates nt 192 to nt 6707) was fused in
frame to the ﬁrst 11 amino acids of the phage T7 gene 10 protein in the
mammalian expression vector pSG5 (Stratagene) using AgeI and NotI
cloning sites.
In vitro translation of b subunit cDNAs and GST
pull-down experiments
Experiments were carried out essentially as described previously (Pragnell
et al., 1994; De Waard et al., 1994; Walker et al., 1998). The a1S I-II loop
(a1S residues 335-432) was ampliﬁed by PCR from a cDNA template
encoding full-length a1S (Genbank accession # M23919), using the forward
primer 59-tca tca gga tcc ggg gaa ttt acc aag gag-39 that contained a BamHI
restriction site and the reverse primer 59-atg cca gaa ttc tct cga ctt cac cag gtc
-39with an EcoRI restriction site. The PCR product was subcloned into
a pGEX-2T vector (Stratagene) and the corresponding protein fragment was
fused with the carboxyl terminus of Glutathione S-Transferase (GST). The
construct was transformed into the bacterial strain BL21(DE3). Cells were
harvested 4 h after isopropyl-1-thio-b-D-galactopyranoside induction by
incubation in phosphate buffered saline buffer in the presence of protease
inhibitors (0.5 mM phenylmethylsulfonyl ﬂuroide and 0.8 mM benzami-
dine). GST-a1S I-II fusion protein was isolated by incubation with
glutathione (GS) Sepharose (Amersham Pharmacia Biotech, Piscataway,
NJ) for 1 h on ice. Control and truncated b constructs subcloned into pSG5
vector were in vitro translated using the T7 coupled reticulocyte system
(Promega, Madison, WI). For radioactivity labeling, 40 mCi of Redivue
L-[35S] methionine (Amersham Pharmacia) was used per 50 ml of TNT in
vitro translation reaction. For protein-protein binding in vitro, 25 ml of the
TNT translated mixture was added to 500 ml binding buffer (50 mM Tris-
HCl pH 7.4, 0.1 mM dithiothreitol, 1 mM MgCl2, 100 mM NaCl, 0.05%
Tween-20) containing ;50 mg GST-a1S I-II loop fusion protein im-
mobilized on GS Sepharose beads. The binding reaction was carried out at
room temperature for 3 h with agitation and was spun for 30 s in a bench-top
centrifuge at 6000 rpm. The pellet containing GS Sepharose beads was
washed four times with 1 ml of binding buffer each time. b proteins were
released from the GS Sepharose by incubation at 1008C for 3 min in SDS-
PAGE loading buffer (50 mM Tris-HCl pH 6.8, 5% b-mercaptoethanol, 2%
SDS, 0.1% bromophenol blue, 10% glycerol). The pulled-down b proteins
and the in vitro translated b proteins were loaded side by side on a 15%
polyacrylamide gel and run for;2 h at 36 mA in SDS-PAGE running buffer
(25 mM Tris, 250 mM glycine, 0.1% SDS, pH 8.3). The gel was dried and
exposed to Kodak X-Omat AR-5 ﬁlm for 20 h at 708C.
Immunoblotting
b proteins were translated in vitro using the same conditions described
above but without radioactive isotope. A 15 ml sample of the translation
reaction was mixed with 15 ml of twice concentrated SDS-PAGE loading
buffer and boiled for 3 min. The 30-ml sample was loaded on a 10%
polyacrylamide gel and run for ;2 h at 36 mA in SDS-PAGE running
buffer. The proteins were electrotransferred onto a Hybond ECL nitro-
cellulose membrane (Amersham Pharmacia) in transfer buffer (48 mM Tris,
pH 8.3, 39 mM glycine, 0.037% SDS, 20% methanol) for 4 h at 35 volts and
48C. The nitrocellulose membrane was blotted with 30 ml of blocking
solution (100 mM Tris, pH 7.5, 150 mM NaCl, 0.05% Tween-20, 5% nonfat
milk) overnight at room temperature with agitation. The nitrocellulose
membrane was blotted for 2 h with 30 ml of blocking solution containing
6 ml of mouse anti-T7 tag monoclonal antibody (Novagen, Madison, WI),
washed three times with washing buffer (100 mM Tris, pH 7.5, 150 mM
NaCl, 0.05% Tween-20), and blotted for 1.5 h with 30 ml of blocking
solution containing 6 ml of donkey anti-mouse IgG POD (Boehringer
Mannheim, Indianapolis, IN). The nitrocellulose membrane was washed
four times with washing buffer and revealed with ECL Western blotting
detection reagents (Amersham Pharmacia). The nitrocellulose membrane
was exposed to Hyperﬁlm ECL high performance chemiluminescence ﬁlm
(Amersham Pharmacia) for 30 s.
Whole cell voltage clamp
Whole-cell recordings were performed as described previously (Strube et al.,
1996) with an Axopatch 200B ampliﬁer (Axon Instruments, Foster City,
CA). Effective series resistance was compensated up to the point of ampliﬁer
oscillation with the Axopatch circuit. All experiments were performed
at room temperature. The external solution was (in mM) 130 TEA
methanesulfonate, 10 CaCl2, 1 MgCl2, 103 TTX, 10 HEPES titrated with
TEA(OH) to pH 7.4. The pipette solution consisted of (in mM) 140 Cs
aspartate, 5 MgCl2, 0.1 EGTA (when Ca2þ transients were recorded) or 5
EGTA (when only Ca2þ current was recorded), and 10 MOPS titrated with
CsOH to pH 7.2. Patch pipettes had a resistance of 1–1.5 MV when ﬁlled
with the pipette solution.
Confocal ﬂuorescence microscopy
Confocal line scan measurements were performed as described previously
(Conklin et al., 1999). Cells were loaded with 4 mM ﬂuo-4 acetoxymethyl
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ester (Molecular Probes, Eugene, OR) for 60 min at room temperature. All
experiments were performed at room temperature. Cells were viewed with
an inverted Olympus microscope with a 203 objective (N.A. 0.4) and an
Olympus Fluoview confocal attachment (Melville, NY). A 488-nm
spectrum line for ﬂuo-4 excitation was provided by a 5-mW Argon laser
attenuated to 20% with neutral density ﬁlters. Line scans consisted of 1000
lines, each of 512 pixels, acquired at a rate of 2.05 milliseconds per line. Line
scans were synchronized to start 100 ms before the onset of the de-
polarization. The time course of the space-averaged ﬂuorescence intensity
change andDF/F units were estimated as follows. The pixel intensity in a line
scan was transformed into arbitrary units and the mean intensity of each line
was obtained by averaging pixels covering the cell exclusively. The mean
resting ﬂuorescence intensity (F) corresponds to the mean intensity of each
line averaged over the ﬁrst 50 ms before stimulation and was used as
a baseline. The change in mean line intensity above baseline (DF) was
obtained by subtraction of F (baseline) from the mean line intensity. DF was
divided by the baseline F for each line in a line scan and was plotted as
a function of time. To construct peak Ca2þ ﬂuorescence versus voltage
curves, we used the highest DF/F line value after the onset of the pulse and
up to the termination of the pulse. Image analyses were performed with NIH
Image software (National Institutes of Health, Bethesda, MD). To obtain
reliable Ca2þ transient versus voltage curves, seven step depolarizations of
50 ms or 200 ms were applied in descending order (from þ90 mV to 30
mV) from a holding potential of 40 mV. Between each depolarization, the
cell was maintained at the resting potential for 30 s to permit recovery of the
resting ﬂuorescence.
Immunostaining
Cells were ﬁxed in 100% methanol and processed for immunostaining as
described previously (Gregg et al., 1996) after 4–5 days after transfection.
For T7-tagged b constructs, the primary antibody was a mouse monoclonal
against the T7 epitope (Novagen) and was used at a dilution of 1:1000. The
secondary antibody was a ﬂuorescein conjugated polyclonal goat anti-mouse
IgG (Boehringer Mannheim, Indianapolis, IN) and was used at a dilution of
1:1000. For a1C, the primary antibody was an anti-rabbit monoclonal
(Chemicon, Temecula, CA) and was used at a 1:100 dilution. The secondary
antibody was a ﬂuorescein conjugated goat anti-rabbit IgG (Chemicon) and
was used at a dilution of 1:750. Confocal images of 0.3–0.4 microns per
pixel were obtained in the Olympus Fluoview using a 403 oil-immersion
objective (N.A. 1.3). Images were Kalman-averaged three times, and the
pixel intensity was displayed as 16 levels of gray in reverse. All images were
acquired with minimal laser power (20% of maximum 5 mW) and
predetermined photomultiplier tube settings to avoid pixel saturation and for
accuracy in the comparison of images.
Curve ﬁtting
The voltage dependence of the Ca2þ conductance and the voltage
dependence of peak intracellular Ca2þ assayed with the 50-ms depolariza-
tion were ﬁtted according to a Boltzmann distribution (Eq. 1) A ¼ Amax/
(1 þ exp((V  V1/2)/k)) where Amax is Gmax or DF/Fmax, V1/2 is the
potential at which A ¼ Amax/2, and k is the slope factor. The voltage
dependence of peak intracellular Ca2þ assayed with a 200-ms depolarization
was ﬁt with Eq. 1 for cells expressing the control, D7, and D21 constructs.
All other truncated variants and full-length b2a produced biphasic bell-
shaped ﬂuorescence versus voltage curves with varying degrees of cur-
vature. In these cases, curves were ﬁt with the modiﬁed Boltzmann
distribution (Eq. 2) DF/F ¼ (V  ECa)/k9 [(DF/Fmax/ (1 þ exp((V  V1/
2)/k)] where ECa is the Ca2þ equilibrium potential, k9 ; 150 mV is
a scaling factor, and the other parameters are the same as in Eq. 1. For D60,
D35, and D29, a chi-square test indicated that Eq. 2 provided a better ﬁt of
the ﬂuorescence versus voltage curve obtained with a 200-ms depolariza-
tion. Parameters of a ﬁt of averages of many cells (population average) are
shown in ﬁgures. The statistics of parameters of the ﬁt of individual cells are
shown in Table 1. Student, chi-square, and analysis of variance (ANOVA)
tests were performed with Analyze-it software (Analyze-it, Leeds, UK).
RESULTS
Based on sequence alignment of several isoforms, domain
D5 of mouse b1a comprises the last 50 to 60 residues of
the carboxyl terminal end of the subunit (Fig. 1 A). To
TABLE 1 Boltzmann parameters of b1 KO myotubes expressing carboxyl terminus truncations of the D5 region of b1a
G-V DF/F-V 50 ms DF/F-V 200 ms
G(max) (pS/pF) V1/2 (mV) k (mV) DF/F(max) V1/2 (mV) k (mV) DF=Fðexp maxÞDF=Fþ90 mV DF/F(max) V1/2 (mV) k (mV) DF=Fðexp maxÞDF=Fþ90 mV
b2-b1 221 6 17 12 6 1.4 4.2 6 0.4 2.8 6 0.6 1.9 6 2.8 7.8 6 1.1 1.0 6 0.1 2.9 6 0.4 7.4 6 2.8 5.9 6 1.2 1.2 6 0.1
(20) (8) (9)
D7 184 6 34 4.7 6 1.9 3.3 6 0.5 1.4 6 0.3 4.3 6 4.1 14 6 2.2 0.9 6 0.1 2.4 6 0.6 4.2 6 3.5 9.7 6 1.4 1.1 6 0.1
(5) (10)* (8) *
D21 170 6 11 8 6 3 4.9 6 0.7 1.5 6 0.6 3.6 6 2.6 9.6 6 1.1 1.1 6 0.1 2.5 6 0.6 1.6 6 4.0 7.8 6 1.1 1.3 6 0.1
(5) (9) (10)
D29 132 6 18 10 6 1.3 4.7 6 0.4 0.6 6 0.2 3.2 6 3.3 8.7 6 1.8 1.1 6 0.2 0.8 6 0.1 0.8 6 1.6 4.8 6 1.0 1.5 6 0.2
(8)* (6)* (7)*
D35 202 6 24 20 6 1.4 5.4 6 0.3 0.5 6 0.1 10 6 2.1 12 6 2.9 1.3 6 0.2 1.1 6 0.3 6.7 6 2.5 9.2 6 1.2 1.3 6 0.2
(8) * (7)* * (8)* *
D60 87 6 10 18 6 1.7 5.1 6 0.3 0.4 6 0.1 12 6 2.1 8.2 6 1.4 1.1 6 0.1 0.7 6 0.1 14 6 1.9 10 6 2.3 2.2 6 0.2
(19)* * (6)* * (6)* * *
b1a 195 6 23 15 6 2.4 4.5 6 0.6 2.7 6 0.5 3.2 6 2.3 7.7 6 0.5 1.0 6 0.1 3.4 6 0.6 8.3 6 1.6 5.8 6 1.1 1.2 6 0.1
(10) (10) (10)
b2a 184 6 36 11 6 1 5.1 6 0.3 0.9 6 0.2 1.9 6 3.3 7.4 6 1.5 1.5 6 0.1 1.7 6 0.4 5.7 6 3.1 7.6 6 1.9 2.3 6 0.4
(6) (10)* * (10) * *
Mean 6 SE of Boltzmann parameters ﬁtted to each cell with number of cells in parenthesis. Parameters of ﬂuorescence versus voltage curves are shown for
50-ms and 200-ms depolarizations. Asterisks indicate data in each column compared to control (b2-b1) with 1-way ANOVA signiﬁcance p , 0.05. G(max),
DF/F(max), V1/2, and k are parameters of the Boltzmann ﬁt. All data was ﬁt with Eq. 1 except ﬂuorescence data in response to 200 ms in cells expressing
D29, D35, and D60 that was ﬁt with Eq. 2. DF/F (exp max) corresponds to the experimental maximum DF/F for a given ﬂuorescence versus voltage curve.
DF/F þ90 mV corresponds to the experimental DF/F at þ90 mV.
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characterize D5, we serially truncated the carboxyl terminus
from back to front and expressed the cDNAs in b1 KO
skeletal myotubes that are entirely devoid of EC coupling
(Beurg et al., 1997). Truncation mutants were identiﬁed by
the number of residues missing from the carboxyl terminus
end according to the sequence shown in Fig. 1 A. The tem-
plate for the truncations was the chimera b2a 1-287 / b1a
325-524, comprising b2a domains D1, D2, D3, and part of
D4 fused to the remaining D4 and D5 of b1a. In b1 KO
myotubes, b2a 1-287 / b1a 325-524 recovered a high-
density L-type Ca2þ current and recapitulated skeletal-type
EC coupling quantitatively (Beurg et al., 1999b). For these
reasons, and because the chimera eliminates potential
contributions of domains D1 and D3 of b1a, it was deemed
the ideal control for the present study. All constructs carried
a T7 epitope tag at the amino terminus for determining
relative levels of protein expression in transfected cells.
Fig. 1 B shows confocal anti-T7 immunoﬂuorescence of
myotubes expressing the control b2-b1 chimera, the tested
truncations, full-length mouse b1a, and a blank consisting of
a nontransfected myotube (NT). Cultures were also in-
cubated with anti-CD8 antibody beads, used here as a marker
to identify transfected myotubes in voltage clamp experi-
ments. Cells were immunostained 4–5 days after trans-
fection, at the same time as voltage-clamp experiments. At
this stage, we found abundant expression of all truncation
variants throughout the length and width of the myotube with
the exclusion of the cell nuclei. In some myotubes, protein
expression was clearly discernable in the submembrane
space, away from the perinuclear regions. This suggested
that, in such cases, a signiﬁcant amount of the expressed
protein had been routed to peripheral sites. A submembrane
staining pattern is signiﬁcant because in the cultured
myotube, EC coupling occurs at peripheral couplings
established between the plasma and SR membranes (Take-
kura et al., 1994). In Fig. 1 B, a preferential peripheral
location of the immunostained protein is evident in the
myotubes expressing D21 or D35. Despite these cases,
however, we found no evident correlation between the
staining pattern and the truncation size. Moreover, submem-
brane staining, distinct from perinuclear staining, was not
evident in all cases. Based on the ﬂuorescence intensity, we
estimated that the truncated variants expressed as well as the
control chimera or wild-type b1a. Previous studies have
shown that the cardiac pore isoform a1C, when transiently
transfected in skeletal dysgenic myotubes, expresses Ca2þ
currents that contribute to Ca2þ dependent EC coupling
(Garcia et al., 1994; Ahern et al., 2000). For this reason we
performed controls to determine whether this isoform might
be present in the b1 KO myotube due to de novo gene
expression. If this were the case, a1C subunits could
potentially interact with the transiently expressed b variants
and the Ca2þ currents generated by these complexes could
contribute to Ca2þ dependent EC coupling. Fig. 1 C shows
immunoﬂuorescence of b1 KO myotubes stained with
a a1C-speciﬁc antibody. We were unable to detect
endogenous a1C expression in either nontransfected b1
KO myotubes or in b1 KO myotubes transfected with the
cardiac/brain b2a isoform. As a positive control, a rabbit
a1C was transiently overexpressed in b1 KO myotubes
using the mammalian expression vector pSG5. In this case,
we found a robust immunoﬂuorescence signal indicating
FIGURE 1 Truncated b variant protein expression and absence of
endogenous a1C expression in b1 KO myotubes. (A) Domain D5 of
mouse b1a according to a sequence lineup of Perez-Reyes and Schneider
(1994). Indicated with numerical coordinates corresponding to the mouse
b1a sequence are the carboxyl terminal end residues of the truncated
variants: D60 (P464), D35 (Q489), D29 (S495), D21 (W503), D7 (A517),
and b2-b1 control (M524). (B) Confocal immunoﬂuorescence of b1 KO
myotubes expressing T7-tagged constructs. Cells were transfected with CD8
cDNA plus the indicated cDNA. b1a corresponds to the full-length mouse
cDNA and NT is a nontransfected myotube. Cells were incubated with CD8
antibody beads, ﬁxed, and stained with anti-T7 primary/ﬂuorescein-
conjugated secondary antibodies. (C) Confocal immunoﬂuorescence of b1
KO myotubes transfected with CD8 plus a1C (a1C), CD8 plus full-length
b2a (b2a), or nontransfected control (NT). Cells were incubated with CD8
antibody beads, ﬁxed, and stained with anti-a1C primary/ﬂuorescein-con-
jugated secondary antibodies. For (B) and (C), pixel intensity was con-
verted to a 16-level inverted gray scale with high-intensity pixels in black
color. Images are 84 3 56 microns and on-focus beads are 4.5 microns in
diameter.
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that exogenous a1C protein was readily detectable by the
technique. This result indicated that de novo expression of
a1C in the b1 KO myotube was very minor or none at all. In
summary, the immunostaining analyses indicated that b
constructs with a carboxyl terminus truncation within the D5
region showed abundant expression in b1 KO myotubes and
that endogenous expression of a1C was undetectable.
To verify the size of the truncated proteins, the cDNAs for
the tested b variants were in vitro translated, followed by
PAGE analysis on a 10% gel and immunoblotting with anti-
T7 antibody (Fig. 2 A). The in vitro translated b1a, b2-b1,
and D60 proteins migrated with apparent molecular weights
of ;74, 65, and 56 kDa respectively, based on the mobil-
ity of ﬁve markers in the same gel. The relative mobilities
(b1a . b2-b1 . D60) are consistent with the theoretical
molecular weights predicted from the cDNAs, respectively
58.9, 54.8, and 48.2 kDa. The lower than expected experi-
mental mobility was probably due to the limited resolution
of the linear polyacrylamide mini-gel system utilized here
for comparative purposes. The mobilities of the rest of the
truncated variants (D7, D21, D29, D35) fell in a ladder
of decreasing molecular weight bracketed by b2-b1 in the
low-mobility end and D60 in the high-mobility end.
We also determined that the truncation of the carboxyl
terminus region did not affect the interaction of the b subunit
with the pore subunit. If this were to be the case, DHPR
surface density would be compromised, given the role of the
a1/b interaction in trafﬁcking Ca2þ channels to the cell
surface. We used the approach developed for studies of a1/b
interactions in neuronal Ca2þ channels (Pragnell et al., 1994;
De Waard et al., 1994; Walker et al., 1998). The a1S I-II
loop was fused to the carboxyl terminus of GST and the
expressed recombinant fusion protein was isolated by
afﬁnity binding to GS Sepharose 4B beads. b constructs
were translated in vitro in the presence of S35-methione and
incubated with GST-(a1S I-II) prebound to GS Sepharose.
Strong interactions between b and the I-II loop are
recognized by the ability of GS-Sepharose beads to
precipitate b bound to the GST-(a1S I-II) fusion protein
(Pragnell et al., 1994). Fig. 2 B shows an autoradiogram of
a 15% polyacrylamide gel of in vitro translated [35S]methi-
onine-labeled b variants pulled down by recombinant GST-
a1S I-II loop fusion protein immobilized on GS Sepharose.
Aliquots of the in vitro translated proteins utilized in the pull-
down assay were run side by side. All b constructs tested in
the present study interacted strongly with the I-II loop,
demonstrated by the high intensity of the bands in the pull-
down lanes compared to the in vitro translated yields in the
right lanes. Furthermore, neither the amount of b variant
protein pulled down by the a1S I-II loop nor the in vitro
translated yields varied with the truncation length. Controls
shown in Fig. 2 C indicated that 1) the GS Sepharose/GST
complex without the a1S I-II loop fusion did not pull down
full-length b1a nor the truncated variants (not shown); and
2) deletion of essential residues in the BID region of
b1a (b1aD278-287; De Waard et al., 1994) eliminated
the interaction with the I-II loop and thus eliminated
the autoradiogram signal. However, both control b1a and
b1aD278-287 were readily expressed in vitro. This result is
consistent with studies in neuronal b isoforms showing that
the BID sequence is essential for an interaction of the b
subunit with the a1 I-II loop (De Waard et al., 1994).
Additional controls shown elsewhere (Cheng et al., 2002)
further demonstrated that 3) the b/I-II loop interaction per-
sisted in high salt (0.4 M NaCl) indicating a high afﬁnity;
FIGURE 2 Size of truncated b variants and interaction with the I-II loop
of the a1S pore subunit. (A) Immunoblot of a 10% SDS-polyacrylamide gel
of in vitro translated b variants. After transfer to nitrocellulose and
incubation with anti-T7 antibody, the blot was revealed by high performance
chemiluminescence. Indicated are the relative mobilities of two out of ﬁve
M.W. markers run in the same gel. (B) Autoradiogram of a 15% SDS-
polyacrylamide gel of in vitro translated [35S]methionine-labeled b variants
pulled down by recombinant GST-a1S I-II loop fusion protein immobilized
on gluthatione(GS)-Sepharose. Lanes 1–7 show pellets (pull-downs) after
2 h of incubation of GS-Sepharose/GST-a1S I-II loop and the indicated in
vitro translated construct. Lanes 8–14 show equal aliquots of the in vitro
translation mixture with each b variant as template. (C) Controls of the pull-
down protocol are shown on an autoradiogram of a 15% SDS-poly-
acrylamide gel of in vitro translated [35S]methionine-labeled b variants.
Lane 1 shows absence of b1a pull down by recombinant GST lacking a1S
I-II loop fusion. Lane 2 shows b1a pull down by GST-a1S I-II loop fusion.
Lane 3 shows absence of pull down of b1aD278-287 by recombinant GST-
a1S I-II loop fusion. Lanes 4 and 5 show in vitro translated b1a and
b1aD278-287.
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and 4) the b interaction was speciﬁc for the I-II loop and not
for the other cytosolic loops of a1S. In summary, the GST
pull-down experiments demonstrated that partial or total
absence of D5 did not affect the ability of the b subunit
protein to bind to the a1S I-II loop, consistent with a similar
deletion analysis conducted in neuronal subunits (De Waard
et al., 1994).
Ca2þ transients are customarily evoked by a brief de-
polarization, and in our previous studies we used voltage
steps with a ﬁxed duration of 50 ms (Beurg et al., 1999a,b).
This stimulation time is more than adequate for completion
of charge movements in the DHPR (Ahern et al., 2003).
However, the slow L-type Ca2þ current also expressed by
the DHPR is only partially activated at the end of the 50-ms
pulse. To investigate a possible contribution of the Ca2þ
current to the EC coupling recovered by the truncated
variants, we compared Ca2þ transients activated by depola-
rizations lasting 50 ms and 200 ms. We used voltage steps in
the range of 30 mV to þ90 mV from a holding potential
of 40 mV to cover both the inward and outward phases of
the Ca2þ current. To avoid cell fatigue and to allow for
ﬂuorescence recovery, we limited the number of pulses to
14 (seven for each duration) and each pulse was applied
every 30 s. Fig. 3 shows the two stimulation protocols in b1
KO myotubes expressing b2-b1 and D60, the latter lack-
ing the entire D5 region. The line scan images in
color correspond to 103 512-pixel lines stacked vertically
from left to right with a total acquisition time (horizontal) of
2.05 s. The time course of the space-averaged ﬂuorescence
intensity is shown above each image and the width of the
horizontal bar reﬂects the duration of the pulse. In the control
case, Ca2þ transients of nearly identical shape and intensity
were obtained with the short and long pulse protocols and the
maximum intensity was nearly the same atþ30 mV andþ90
mV. Both features, namely the absence of pulse duration
dependence and persistence at large positive potentials, are
hallmarks of skeletal-type EC coupling (Melzer et al., 1986).
In contrast, Ca2þ transients activated in the myotube
expressing D60 were barely detectable with the short pulse,
consistent with a previous study (Beurg et al., 1999b).
However, in response to the 200-ms depolarization, Ca2þ
transients became comparatively larger and behaved in
a biphasic manner, increasing from 10 mV to þ30 mV and
decreasing at more positive potentials. Furthermore, the rate
of rise of the ﬂuorescence signal during the depolarization
was noticeably slower at all potentials compared to the
control case. The decay of the Ca2þ transient after the
stimulus was also much slower than in controls, requiring
several seconds for the signal to reach resting level. To avoid
excessive photobleaching, in Fig. 3 we limited the total line
scan time to 2.05 s per pulse. Hence, the decay phase of the
Ca2þ transient for the myotube expressing D60 is not entirely
evident at all potentials. However, it is clear from the line
scan images that resting ﬂuorescence levels were consis-
tently reached before each stimulation. It is conceivable that
the slow decay kinetics may be due to the much weaker
stimulation of the Ca2þ pump produced by the small Ca2þ
transients expressed by D60. In summary, Ca2þ transients
activated by D60 had severely altered kinetics and voltage
dependence. The protocol with the longer depolarization
suggested a direct involvement of the Ca2þ current in the
ﬂuorescence signal in the myotube expressing D60 but not
for the control chimera. This was indicated by the decrease in
Ca2þ transient amplitude at positive potentials. Therefore,
we further investigated if the Ca2þ current activated by the
longer depolarization in myotubes expressing D60 was
involved in triggering SR Ca2þ release.
Ca2þ currents expressed by b2-b1 and D60 are shown in
Fig. 4 A. The Ca2þ current of nontransfected cells (not
shown) was below the limit of detection, and was ,20 pA/
cell or ,0.05 pA/pF for the smallest cells having the lowest
capacitative noise. The truncation produced a slight re-
duction in the activation kinetics and, when currents were
corrected for cell size, D60 expressed a Ca2þ current density
lower than the control chimera (Fig. 4 B). In a previous study
(Beurg et al., 1999b), we showed that b2-b1 and D60
generated a comparable density of charge movements, hence
the reduction in Ca2þ current is probably related to the loss
of EC coupling and retrograde coupling rather than due to
a reduction in the membrane density of DHPR complexes
(Nakai et al., 1996). The Boltzmann parameters of the Ca2þ
conductance for all truncations are shown in Table 1,
at a resolution of 5 mV in the range of 35 to þ80 mV
from a holding potential of 40 mV. The most severe reduc-
tions in maximum Ca2þ conductance density (Gmax)
were observed for D29 and D60, and for the Ca2þ current
recovered by the latter construct, there was also a positive
shift in half-activation potential (V1/2) of ;6 mV. This was
also apparent in the current versus voltage relationships
shown in Fig. 4 B. The graphs in Fig. 4, C and D, present
the voltage dependence of the total ionic charge, in pC/
pF, which entered the cell during the 50- and 200-ms
depolarizations utilized for triggering Ca2þ transients.
Ca2þ currents were obtained concurrent with the cell Ca2þ
ﬂuorescence, and the voltage dependence of the latter is
described in detail below (see Fig. 7). The ionic charge,
which is mostly Ca2þ, was obtained by integration of the
pulse current with examples at þ30 mV provided in the
insets of Fig. 4, C and D. Near maximum Ca2þ entry within
this series of stimulations occurred at ;þ30 mV, consistent
with the voltage dependence of the Ca2þ current measured at
a much higher resolution in voltage in Fig. 4 B. For D60,
Ca2þ entry was minimal with the 50-ms depolarization and
increased ;130-fold with the 200-ms depolarization. Such
a large difference in Ca2þ entry produced by the two pulses
could explain the pronounced dependence of the Ca2þ
transients expressed by D60 on pulse duration. Furthermore,
the largest Ca2þ transient for D60 occurred during the
depolarization toþ30 mV, a potential that also generated the
largest Ca2þ entry. Interestingly, signiﬁcantly larger Ca2þ
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entries occurred in myotubes expressing b2-b1 at either 50
or 200 ms. However, the excess of Ca2þ had no obvious
effect on the magnitude of the Ca2þ transient (Fig. 3). This
result underscores the signiﬁcant change in EC coupling
mechanism produced by the truncation of domain D5. Taken
together with the observations in Fig. 3, the data in Fig. 4
suggested that either the Ca2þ current was responsible for
the ﬂuorescence change generated in the D60-expressing
myotube, or the Ca2þ current triggered Ca2þ release from the
SR via a Ca2þ-induced Ca2þ release mechanism.
We quantiﬁed the ﬂuorescence increase due to Ca2þ
entering the cell after blocking Ca2þ release from the SR
with 0.1 mM ryanodine. To ensure a complete elimination
of the ﬂuorescence change due to EC coupling, myotubes
were exposed to ryanodine for 30 min. Because whole-cell
recordings of the same quality could not be consistently
maintained for such a prolonged time, we compared separate
control and ryanodine-treated cells within the same batch of
transfected cells. The time course of Ca2þ transients of b1
KO myotubes expressing b2-b1 or D60 in control external
solution and external solution supplemented with ryanodine
are shown respectively in Fig. 5, A and B. To maximize the
ﬂuorescence signal due to Ca2þ entering the myotube, we
used a 200-ms depolarization to þ30 mV. Ca2þ currents
stimulated by the depolarization are shown below the Ca2þ
transients. The treatment with ryanodine drastically reduced
the stimulated ﬂuorescence. Further addition of 0.5 mM
La3þ and Cd2þ to the external solution completely blocked
the Ca2þ current and this intervention eliminated all changes
in cell ﬂuorescence (gray traces). In myotubes exposed to
ryanodine, we investigated the relationship between the
ﬂuorescence increase and the Ca2þ current injected into the
cytoplasm during the 200-ms depolarization. Ca2þ current
densities expressed by the control and D60 constructs were
mildly reduced in ryanodine treated cells. However, differ-
ences relative to control cells expressing the same constructs
were not statistically signiﬁcant. This can be seen by com-
paring Ca2þ entry versus voltage curves obtained under the
same conditions in Fig. 5, C andD, with their counterparts
without ryanodine in Fig. 4,C andD. Thus atþ30 mV, Ca2þ
entry during the 200-ms depolarization was 0.956 0.08 and
0.27 6 0.07 pC/pF respectively for b2-b1 and D60
expressing myotubes treated with ryanodine, and was 0.98
6 0.21 and 0.35 6 0.08 pC/pF respectively for nontreated
control myotubes. For the control chimera (Fig. 5 C), the
ﬂuorescence change was strictly proportional to the mag-
FIGURE 3 Ca2þ transients expressed by b2-b1 and D60 revealed by 50 ms and 200-ms depolarizations. Confocal line scan images of ﬂuo-4 ﬂuorescence
are shown for a b1 KO myotube expressing b2-b1 (left) and a separate myotube expressing D60 (right). For visual reference pseudocolors, in DF/F units, are
blue,0.2; green,2; and yellow.4. In the images, the total line scan duration (x axis) was 2.05 s and the cell dimension (y axis) was (in microns) 21 for b2-
b1 and 30 for D60. Traces above the images show the integral of the image ﬂuorescence in DF/F units indicated by the vertical bars. Note difference in DF/F
scale for b2-b1 and D60. Myotubes were held at a resting potential of40 mV and depolarized for 50 ms or 200 ms. The depolarization time is indicated by the
horizontal bar under the ﬂuorescence time course.
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nitude of the Ca2þ current at each potential in the range of
30 to þ90 mV. Consequently, the curve was bell-shaped
and centered at approximatelyþ30 mV. At this potential, the
contribution of the Ca2þ current expressed by the control
chimera was 0.19 6 0.04 DF/F (n ¼ 4) and this value was
15-fold lower than the maximum ﬂuorescence change
observed in the presence of a functional SR (2.9 6 0.4
DF/F; n ¼ 9; Table 1). The ﬂuorescence contributed by the
Ca2þ current in myotubes expressing D60 was barely
detectable above the background noise (Fig. 5 D). We
attributed this result to the lower Ca2þ current density
expressed by this truncated variant, which is evident in the
Ca2þ entry versus voltage curve. For D60, the ﬂuorescence
change at þ30 mV was 0.08 6 0.02 DF/F (n ¼ 4), whereas
in external solution without ryanodine it was ninefold higher
(0.7 6 0.1 DF/F; n ¼ 6; Table 1). These results ruled out
a major direct contribution of the Ca2þ current to the
ﬂuorescence signal during EC coupling and suggested that
D60 changed the nature of the EC coupling trigger signal
from one controlled by voltage to one involving the Ca2þ
current.
The presence of Ca2þ dependent EC coupling in myotubes
expressing truncated b variants was further tested by
measuring Ca2þ transients in the same cell before and after
a rapid change in external Ca2þ concentration. In preliminary
experiments, a change in external Ca2þ from the standard 10
mM external Ca2þ to a submillimolar concentration in-
variably made the pipette seal unstable. However, a change
in external Ca2þ from low to high was more successful. This
protocol is shown in Fig. 6 for the control chimera, D21,
D29, and D60. Myotubes were initially voltage clamped in
an otherwise standard external solution but containing 0.5
FIGURE 4 Voltage dependence of Ca2þ currents and Ca2þ entry in myotubes expressing b2-b1 and D60. (A) Representative Ca2þ currents in b1 KO
myotubes expressing the control chimera or D60. Cells were depolarized for 200 ms to the indicated potentials from a holding potential of 40 mV. The
vertical scale bar is 0.5 nA in both cases. (B) Peak Ca2þ current versus voltage relationship in response to a 500-ms depolarization from a holding potential of
40 mV. (C, D) The voltage dependence of the ionic charge entering the cell calculated by integration of the Ca2þ current during pulses of 50 ms (ﬁlled
symbols) or 200 ms (open symbols) from a holding potential of40 mV. Inserts show representative Ca2þ currents in b1 KO myotubes expressing b2-b1 (225
pF) or D60 (300 pF). Scale bars are 0.5 nA (vertical) and 50 ms (horizontal) in both cases. Cells were depolarized from 40 mV to þ30 mV.
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mM Ca2þ and depolarized to þ30 mV for 200 ms. The Ca2þ
transient elicited in this condition was acquired concurrently.
The myotube was then fast-perfused for 1 s with external
solution containing 10 mM Ca2þ before and during the same
depolarization and line scan protocols. The perfusion solu-
tion was passed through a large-bore pipette placed near the
cell, with the pipette connected to a pressurized manifold
(ALA Scientiﬁc, Westbury, NY). The change in external
solution was conﬁrmed by the increase in Ca2þ current
shown in Fig. 6 for each cell under the corresponding line
scan. Increases in Ca2þ current, indicative of a change in
external Ca2þ, varied between two- and ﬁvefold for the con-
trol construct and D21, and between 5- and 10-fold for the
most severe trunctations. As expected, Ca2þ transients ex-
pressed by the control construct were similar in the low
and high external Ca2þ solutions. We found that Ca2þ
transients evoked in myotubes expressing D7 (see Fig. 8 A)
or D21 (Fig. 6) were also unaffected by the change in
external Ca2þ. However, Ca2þ transients in myotubes
expressing the more severe truncations such as D29 and
D60 were detectable in the high Ca2þ solution but not in
the low Ca2þ solution. The limit of ﬂuorescence change
detection, based on microscope settings and the average
resting ﬂuo-4 ﬂuorescence, was ;0.05 DF/F units; that is,
we could detect a ;5% change above the cell resting
ﬂuorescence. Using a pseudoratiometric equation for esti-
mating the cytosolic free Ca2þ and assuming a resting free
Ca2þ of 100 nM (Conklin et al., 1999), the nominal limit
FIGURE 5 Contribution of the Ca2þ current to the cytosolic ﬂuorescence in myotubes expressing b2-b1 and D60. (A, B) Representative Ca2þ transients
obtained from the integrated confocal line scan ﬂuo-4 ﬂuorescence are shown in two myotubes expressing b2-b1 (A) and two myotubes expressing D60 (B).
Ca2þ transients were evoked by a 200-ms depolarization to þ30 mV from a holding potential of 40 mV. The period of the stimulation is indicated by the
horizontal lines. Experiments were conducted in the absence (control) or presence of 0.1 mM ryanodine added to the external solution 30 min before
establishing whole cell clamp. Ca2þ current densities in pA/pF are shown in the same cell below the Ca2þ transients. Traces in gray show the complete
elimination of the Ca2þ transient and the Ca2þ current after addition of 0.5 mM LaCl3 and 0.5 mM CdCl2 to the bath solution of the same cell. Note changes in
DF/F and pA/pF scales. (C, D) Voltage dependence of the peak cytosolic Ca2þ increase produced by Ca2þ entry in myotubes exposed to ryanodine. Ca2þ
charge was calculated from the running integral of the Ca2þ current in response to 200-ms depolarizations from a holding potential of 40 mV. The peak
ﬂuorescence change detected during the depolarization to 30 mV were 0.07 6 0.01 DF/F and 0.06 6 0.01 DF/F respectively for b2-b1 and D60, and were
due to background noise. For D60, the background ﬂuorescence noise at30 mV and the peak ﬂuorescence change atþ30 mV were not signiﬁcantly different
(t-test signiﬁcance p ¼ 0.14).
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of resolution of free Ca2þ change was ;150 nM. Thus,
changes in free Ca2þ concentration under this limit could
have taken place in myotubes expressing D29, D35, or D60
when stimulated in 0.5-mM external Ca2þ and would have
escaped detection. We noticed that the rise time of the Ca2þ
transient was slower when myotubes were subjected to the
rapid perfusion protocol compared to myotubes kept in 10
mM external Ca2þ all the time. This was especially obvious
for D29 and D60 but much less for the control chimera and
D21. It could be that during the exposure to 0.5 mM external
Ca2þ, which lasted up to 15 min, the SR Ca2þ content was
gradually reduced. This might have reduced the Ca2þ
sensitivity of SR Ca2þ release which is known to be con-
trolled by the luminal Ca2þ concentration (Lukyanenko
et al., 2001). The lower SR Ca2þ load might have also
reduced the Ca2þ release rate by reducing the Ca2þ gradient
across the SR. Despite these limitations, the protocol was
extremely useful for comparative purposes and a summary of
this data is presented below (see Fig. 8 A). From these results
we concluded that the Ca2þ current contributed in a signif-
icant manner to the signal that releases Ca2þ from the SR in
myotubes expressing D29 and D60. However this was not
the case for the control chimera and for D21-expressing
myotubes.
Ca2þ dependent EC coupling can be distinguished from
purely voltage dependent EC coupling by the shape of the
Ca2þ ﬂuorescence versus voltage relationship, because
the former mechanism follows the voltage dependence of the
Ca2þ current. These relationships are shown in Fig. 7 for the
control chimera, D60, and the four smaller deletions within
domain D5, all obtained by integration of the confocal line
scan ﬂuorescence. The pulse protocol for obtaining these
curves was the same described in Fig. 3. The DF/F value
reached at the end of the depolarization was plotted as
a function of voltage for depolarizations of 50 ms (ﬁlled
symbols) or 200 ms (open symbols). The duration of the
pulse did not affect the sigmoidal voltage dependence of
Ca2þ transients expressed by the control construct, in agree-
ment with observations in adult skeletal muscle (Melzer
et al., 1986). However, myotubes expressing D7 and D21
had sigmoidal ﬂuorescence versus voltage curves with a
higher maximum ﬂuorescence at large positive potentials
(DF/Fmax) for the 200-ms than for the 50-ms stimulation.
Moreover, as a function of truncation length, we observed a
progressive reduction in theDF/Fmax produced by the 50-ms
stimulation, although the shape of these curves was sigmoidal
in all cases. In contrast, ﬂuorescence versus voltage curves
generated with the 200-ms pulse showed a signiﬁcant
change in shape, from sigmoidal for D7 and D21, to bell-
shaped for D29, D35, and D60. For the later cases there
was an increase in ﬂuorescence in the range of
30 mV to þ20 mV, a maximum at ;þ30 mV, and an
incremental decline in ﬂuorescence in the range of þ40 mV
to þ90 mV. To quantify these observations, we ﬁtted the
curves obtained with the 200-ms depolarization for D29,
D35, and D60 with a modiﬁed Boltzmann equation that takes
into account the Ca2þ equilibrium potential (Eq. 2) while the
rest of the curves in Fig. 7 were ﬁtted with a conventional
Boltzmann equation (Eq. 1). The ﬁt of the mean ﬂuorescence
is indicated by the curve, and chi-square tests of the ﬁt with
Eq. 2 are provided in the ﬁgure legend. We further gauged
the degree of curvature of the ﬂuorescence versus voltage
plots at positive potentials by computing the ratio of
ﬂuorescence at the experimental maximum and the ﬂuores-
cence at þ90 mV ([DF/F exp max]/[DF/F þ90 mV]). The
Boltzmann parameters of the ﬁt of each cell and the
ﬂuorescence ratios at 50 ms and 200 ms are shown in Table
1 along with the statistical signiﬁcance and the number of
cells. The [DF/F exp max]/[DF/F þ90 mV] ratio was .1
with ANOVA signiﬁcance p , 0.05 for the more severe
truncations and for full-length b2a when measured with the
200-ms depolarization. However, for the moderate trunca-
tions, the ratio was ;1, within a 10% error. To conﬁrm the
basis of the bell-shaped ﬂuorescence versus voltage relation-
ships, we correlated the bending ratio [DF/F exp max]/[DF/
F þ90 mV] computed from the 200-ms depolarization with
the ratio of Ca2þ transient amplitude at þ30 mV in 10-mM
and 0.5-mM external Ca2þ using the protocol described in
Fig. 6. Fig. 8, A and B, shows histograms of the two indices
for all the constructs tested in this study, whereas Fig. 8 C
plots one index against the other. We found a clear cor-
relation between these two indices, strongly suggesting that
for the most severe truncations, the Ca2þ current contri-
buted to trigger the Ca2þ transient thus explaining the change
in the shape of the ﬂuorescence versus voltage curve. In
summary, a dependence of the Ca2þ transient amplitude on
pulse duration was observed for all the truncated variants.
However, only the most severe truncations, namely D29,
D35, and D60, had bell-shaped ﬂuorescence versus voltage
relationships, consistent with the presence of an EC coupling
component triggered by the Ca2þ current. Furthermore, as
a function of truncation length, there was a continuous
decrease in the maximum amplitude of the Ca2þ transient
triggered by the 50-ms depolarization. Because the voltage
dependence of the curves measured with the 50-ms de-
polarization was strictly sigmoidal, this result suggested a
progressive loss of voltage-dependent coupling. At the
same time, the progressive change in the shape of the plots
determined by the 200-ms depolarization, from sigmoidal to
biphasic bell-shaped, suggested a progressive gain in Ca2þ
current dependent EC coupling.
If the Ca2þ current triggered EC coupling in the myotubes
expressing the severely truncated constructs, the rate of rise
of the ﬂuorescence signal and the rate of Ca2þ entering the
cell should be correlated. Fig. 9 A shows Ca2þ transients and
Ca2þ currents produced by a 200-ms depolarization to þ30
mV in myotubes expressing the control and D60 constructs.
As already noted, Ca2þ transients obtained with D60 were
considerably slower than those obtained with the control
chimera. To correlate the time course of the Ca2þ transient
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and the Ca2þ current, we compared the cumulative sum of
the Ca2þ charge during the depolarization (i.e., the running
integral of the Ca2þ current) with the ﬂuorescence signal.
Because Ca2þ ﬂuorescence was measured in a weakly
buffered internal solution containing 0.1 mM EGTA, the cell
ﬂuorescence tracked Ca2þ accumulation rather than the rate
of Ca2þ release from the SR (Melzer et al., 1984). Hence, we
deemed it reasonable to correlate Ca2þ ﬂuorescence with
Ca2þ charge accumulation. The digitized data corresponds to
the line by line confocal ﬂuorescence in DF/F units (gray)
and the smooth curve (black) is the time course of the
cumulative Ca2þ charge. For the myotube expressing the
control chimera, the ﬂuorescence signal increased earlier and
faster than the Ca2þ charge. Furthermore, the ﬂuorescence
signal saturated before termination of the 200 ms pulse while
the Ca2þ charge continued to increase for as long as the pulse
was at þ30 mV. In contrast, there was a much closer
agreement in the kinetics of the two signals in the myotube
expressing D60. The increase in ﬂuorescence occurred
in parallel with Ca2þ charge accumulation and this was
FIGURE 7 Sigmoidal and bell-shaped voltage dependencies of Ca2þ transients in myotubes expressing truncated b variants. Ca2þ transients in DF/F units
were measured in b1 KO myotubes expressing the indicated truncated variant using a depolarization of 50 ms (ﬁlled symbols) and 200 ms (open symbols) from
a holding potential of 40 mV. Ca2þ transients were measured at the end of each depolarization from the time course of the integrated confocal ﬂuo-4
ﬂuorescence. The lines correspond to a Boltzmann ﬁt of the population mean DF/F obtained from the number of cells reported in Table 1 for each construct. All
ﬂuorescence versus voltage curves were ﬁt with Eq. 1 except those obtained with the 200-ms depolarization in myotubes expressing D29, D35, and D60, which
were ﬁt with Eq. 2. Parameters of the ﬁtted lines (DF/Fmax in DF/F units, V1/2 in mV, and k in mV) are b2-b1: 2.5,5.5, 8.2 for 50 ms and 2.9,7.1, 7.8 for
200 ms; D7: 1.4, 1.2, 16.4 for 50 ms and 2.4, 0.7, 11.2 for 200 ms; D21: 1.5,7.6, 8.7 for 50 ms and 2.4, 9.4, 6.9 for 200 ms; D29: 0.6, 1.2, 11 for 50 ms and
0.9, 2.9, 8 for 200 ms; D35: 0.5, 9, 9.6 for 50 ms and 1.1, 10.6, 8.7 for 200 ms; and D60: 0.4, 11.8, 6.8 for 50 ms and 0.8, 13.2, 7.1 for 200 ms. Chi-square
signiﬁcance of the ﬁt with Eq. 2 versus a ﬁt of the same data with Eq. 1 were respectively as follows: D29: p ¼ 0.05 vs. p ¼ 0.085; D35: 0.036 vs. 0.078; and
D60: p ¼ 0.023 vs. 0.2. Symbols are the same as in Fig. 9.
FIGURE 6 External Ca2þ dependence of Ca2þ transients expressed by truncated b variants. Line scan images and time courses of integrated ﬂuo-4
ﬂuorescence in DF/F units are shown for the same b1 KO myotube expressing the indicated variant in external solution with 0.5 mM Ca2þ (left) and 10 mM
Ca2þ (right). Ca2þ transients were evoked by a 200-ms depolarization to þ30 mV from a holding potential of 40 mV. In the images, the total line scan
duration (x axis) was 2.05 s and the cell dimension (y axis) was (in microns) 36 for b2-b1; 25 for D21; 34 for D29; and 47 for D60. For visual reference, the
color table was the same used in Fig. 3. Myotubes were initially voltage clamped and stimulated in external solution containing 0.5 mM Ca2þ and later fast-
perfused with control external solution for 1 s before and during the same stimulation. The change in external solution and the depolarization are indicated by
the line diagrams in black. Ca2þcurrents are shown before and after the solution change. Scale bars are 0.5 nA and 100 ms. The mean resting ﬂuorescence of
myotubes expressing D29 and D60 is indicated by the gray line. Fluorescence intensity scale denotes 1 DF/F for b2-b1, D29, and D60; and 2 DF/F for D21.
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especially obvious during the second half of the 200-ms
pulse. Thus in cells expressing D60, the kinetics of the Ca2þ
transient was consistent with the Ca2þ current serving as
trigger for SR Ca2þ release. In some myotubes expressing
D60 we could observe a small fast component of the
ﬂuorescence signal at the start of the depolarization which
could be interpreted as a residual voltage dependent com-
ponent. However, this component was not consistently ob-
served. In Fig. 9 B, we compared the rate of ﬂuorescence
change during the ﬁrst 20 ms (dDF/F / dt) as a function of
voltage for myotubes expressing the control construct, the
control construct in the presence of 0.1 mM ryanodine (open
inverted triangles), and each of the ﬁve carboxyl terminal
truncations. In control cells, dDF/F / dt increased with
voltage in a sigmoidal manner and reached the highest
maximum at potentials more positive than þ30 mV.
Treatment with ryanodine, reduced the rate of ﬂuorescence
change;50-fold, consistent with the absence of a functional
SR in this group of cells. For a moderate truncation such as
D7, the maximum rate was statistically indistinguishable
from control at all voltages (t-test signiﬁcance p . 0.1). For
the other truncations, the maximum rate at potentials more
positive than þ30 mV were two- to eightfold lower, and the
decrease for D21 was less severe than for D29, D35, and D60
(t-test signiﬁcance p , 0.001 versus control at þ90 mV).
Hence, the decrease in the rate of cytosolic Ca2þ ac-
cumulation was proportional to the truncation length. In
summary, truncation of D5 region of b1a eliminated the fast
EC coupling typical of skeletal myotubes. Furthermore, the
slow EC coupling observed in myotubes expressing D60
appears to have its kinetic basis on the slow time course of
the skeletal DHPR Ca2þ current.
DISCUSSION
The results of the present work show that elimination of
carboxyl terminus of the DHPR b1a subunit modiﬁes EC
coupling in skeletal myotubes, transforming it from a process
controlled by voltage to a much weaker and slower coupling
process controlled by the Ca2þ current. As a function of
truncation length, we observed an overall decrease in the
amplitude of Ca2þ transients with evident changes in the
shape of the Ca2þ ﬂuorescence versus voltage relationship
and slowing of the kinetics of the Ca2þ transient. For the
most severe truncations, we also observed a dependence of
Ca2þ transients on external Ca2þ. These observations are
consistent with the emergence of Ca2þ dependent EC coup-
ling whereby Ca2þ entering the cell via the DHPR induces
SR Ca2þ release, presumably by Ca2þ dependent activa-
tion of RyR1, although the participation of RyR3 cannot
be discarded (Sheridan et al., 2002b). Additionally, there
was a continuous decrease in voltage-dependent coupling
indicated by the fact that Ca2þ transients activated by
the 50-ms depolarization became smaller as a function of
truncation length. Finally, the data showed a moderate
decrease in Ca2þ conductance of two- to threefold for the
most severe D29 and D60 truncations, whereas the control
chimera expressed the same Ca2þ conductance of b1a-
transfected myotubes (Table 1). The control b2-b1 chimera
and D60 were previously shown to express a comparatively
large charge movement density of 5.1 6 0.5 and 4 6 0.3 fC/
pF, respectively (Beurg et al., 1999b). In addition, a truncated
b1a lacking 35 residues from the carboxyl terminus also
expressed a high charge movement density of 5 6 0.8 fC/pF
(Beurg et al., 1999b). For these reasons, we do not believe
FIGURE 8 Ca2þ dependent EC coupling as a function of the truncation length. (A) Histograms of the ratio of Ca2þ transient amplitude atþ30 mV obtained
as described in Fig. 5 in 0.5 and 10 mM external Ca2þ for the indicated number of cells and b variants. DF/F 10 Ca2þ / DF/F 0.5 Ca2þ ¼ 1 denotes absence of
an EC coupling component that depends on Ca2þ entering the cell. (B) Histograms of the ratio DF/F exp max/ DF/Fþ90 mV described in the text and Table 1
for the indicated number of cells and b variants. DF/F exp max/ DF/F þ90mV ¼ 1 implies saturation of the Ca2þ transient versus voltage relationship
indicative of voltage dependent EC coupling. (C) Correlation of the DF/F exp max/ DF/F þ90mV ratio and the DF/F 10 Ca2þ / DF/F 0.5 Ca2þ ratio for the
same variants (correlation coefﬁcient r2 ¼ 0.8).
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that the decrease in Ca2þ conductance observed in the
severely truncated b variants may be ultimately explained by
a decrease in DHPR surface expression, although this
possibility remains to be investigated in detail. Studies in
RyR1 KO myotubes show that the bulk of charge move-
ments remain in place after RyR1 is eliminated, however, the
Ca2þ current density decreases 5- to 10-fold (Nakai et al.,
1996). Thus, expression of the DHPR Ca2þ current appears
to be under the speciﬁc control of RyR1 by a so-called
retrograde signal, from RyR1 to the DHPR. We have
recently shown that this retrograde signal is strongly
inﬂuenced by molecular determinants present on the
amino-terminus of b2a (Ahern et al., 2003). Consequently,
it is entirely possible that the loss in Ca2þ conductance in
the severely truncated variants might represent a loss of
retrograde signaling promoted by the truncated b subunit
variants. Furthermore, because signals in the retrograde and
orthograde directions have closely related structural deter-
minants (Tanabe et al., 1990b; Ahern et al., 2001b), it would
be unexpected to lose voltage-dependent EC coupling
without losing retrograde enhancement of the Ca2þ current
at the same time.
Drastic changes in EC coupling were previously reported
when a1S, the skeletal pore isoform, was replaced by a1C,
the cardiac pore isoform, in the cellular context of a primary
dysgenic a1S-null skeletal myotube (Tanabe et al., 1990a).
The Ca2þ ﬂuorescence versus voltage curve expressed by
a1C in dysgenic myotubes had a maximum at ;þ30 mV
followed by a continuous decrease at more positive poten-
tials. The biphasic nature of this relationship, together with
FIGURE 9 Initial rate of cyto-
solic Ca2þ increase during the
Ca2þ transient in myotubes express-
ing truncated b variants. (A) Ca2þ
currents and Ca2þ transients in
myotubes expressing the control
chimera (left) and D60 (right) were
obtained in response to a 200-ms
depolarization from a holding po-
tential of 40 mV to þ30 mV in
external solution with 10 mM Ca2þ.
The digitized trace (gray) shows
ﬂuo-4 ﬂuorescence in DF/F units
obtained during the confocal line
scan. Each dot corresponds to the
mean ﬂuorescence of a single 512-
pixel line acquired at a rate of 2.05
ms per line. The black trace shows
the cumulative integral of the Ca2þ
current (running integral) in fC (pA
3 ms) superimposed on the ﬂuo-
rescence trace. Actual Ca2þ currents
are shown below the trace of
ﬂuorescence. (B) The voltage de-
pendence of the initial rate of
ﬂuorescence increase is shown for
the indicated b variants. dDF/F / dt
was determined from the initial 20
ms of the Ca2þ transient. The lines
correspond to a Boltzmann ﬁt
(Eq. 1) of the mean dDF/F / dt.
Parameters of the ﬁt were (d(DF/F)/
dt)max (in DF/F units) ¼ 0.08,
0.06, 0.04, 0.02, 0.02, and 0.01;
V1/2 (in mV) ¼ 0.6, 8.7, 0, 2.8,
12.3, and 5.7; k (in mV) ¼ 10.2,
13.8, 10.6, 13.9, 10.9, and 6.7; for
myotubes expressing b2-b1 (n ¼
17), D7 (n¼ 18), D21 (n¼ 19), D29
(n ¼ 13), D35 (n ¼ 15), and D60 (n
¼ 12), respectively. Empty inverted
triangles (n ¼ 4) correspond to b1
KO myotubes expressing b2-b1
treated with 0.1 mM ryanodine for
30 min before line scan acquisition.
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a dependence of Ca2þ transients on external Ca2þ, showed
that Ca2þ-dependent EC coupling could be implemented in
skeletal myotubes by a hybrid DHPR composed of a cardiac
pore subunit and skeletal nonpore subunits. The observation
in a1S-null myotubes gave strong support to the notion that
the pore subunit of the skeletal DHPR harbored a unique
signal for triggering skeletal EC coupling (Tanabe et al.,
1990a). In light of the present data, this concept must be
expanded because elimination of the D5 region of b1a, in the
context of a skeletal myotube lacking the b1 gene but
expressing wild-type a1S, changed the EC coupling trigger
signal in a manner similar to the change observed when a1C
replaced a1S. Previous studies in b1 KO myotubes
depolarized for 50 ms had shown that b2a expressed weak
skeletal-type EC coupling (Beurg et al., 1999a). However, the
longer stimulus used here demonstrated that a large compo-
nent of the Ca2þ transient recovered byb2a is activated by the
Ca2þ current (see Table 1). The similar outcome of these two
sets of experiments, namely a1S replacement by a1C versus
b1a replacement by b2a, suggests that the a1S/b1a pair, and
not either subunit alone, controls the EC coupling signal in
skeletal myotubes.
It could be argued that in skeletal b1 KO myotubes there is
reexpression of a1C due to pleotropic effects arising from
either the absence of b1a or the reintroduction of exogenous
b variants. Thus the Ca2þ-dependent EC coupling observed
in our expression systemmight have originated from a DHPR
containing the reexpressed a1C isoform. The experimental
evidence indicates that this possibility is remote. First, the
activation kinetics of the Ca2þ current expressed by D60 was
even slower than that expressed by the control chimera with
bona ﬁde skeletal-type EC coupling, although a complete
kinetic analysis has not yet been completed. A similar
conclusion was reached recently by comparing the activation
kinetics of Ca2þ currents recovered by b2a and b1a in b1
KO and double b1/RyR1 KO myotubes (Ahern et al., 2003).
Hence, the truncated variant, as well as b2a, recovered a slow
skeletal-type Ca2þ current and not the much faster Ca2þ
current expressed by a1C. This result would not be expected
if b2a paired up with a1C, because Ca2þ currents generated
by the a1C/b2a pair are considerably faster (Kamp et al.,
1996). Second, the half-activation potentials of the Ca2þ
current recovered by the truncated b variants were þ10 to
þ20 mV (Table 1), whereas the V1/2 expressed by a1C in
skeletal myotubes is signiﬁcantly more negative (Garcia
et al., 1994). Third, transfection of b2a in dysgenic a1S-null
myotubes does not result in expression of Ca2þ currents (not
shown). Therefore, a1S is essential for the b-mediated
recovery of DHPR function in skeletal myotubes. Finally,
immunoﬂuorescence staining with a primary antibody spe-
ciﬁc for a1C showed that a1C could not be detected in b1
KO myotubes (Fig. 1 C). For all these reasons, we are rather
certain that a DHPR that included a1S was responsible for
Ca2þ dependent EC coupling observed in b1 KO myotubes
expressing the truncated b variants.
The systematic truncation approach provided clues on at
least one structural motif present in the D5 region potentially
responsible for the changes in EC coupling. Ca2þ-dependent
EC coupling was clearly noticeable in the severely truncated
D29, D35, and D60 constructs and much less in the D21 and
D7 constructs. This could be inferred from the exaggerated
curvature of the ﬂuorescence versus voltage plots for D29,
D35 and D60 and by the dependence of the Ca2þ transients
generated by these variants on external Ca2þ. The D5 region
of b1a (Fig. 1 A) contains a quasi-heptad repeat motif,
namely L478(n)-V(nþ7)-V(nþ14)-L(nþ22)-L(nþ28), that
is progressively removed by the D21, D29, and D35
truncations and is absent in D60. Heptad repeats are known
to be important in protein-protein interactions responsible for
gating (McCormack et al., 1991; Garcia et al., 1997). A
conserved heptad repeat is present in voltage-gated Kþ, Naþ,
and L-type Ca2þ channels in the S4-S5 cytosolic linker
immediately after the S4 charges. In the Shaker Kþ channel,
alanine substitutions in the heptad repeat leads to large
positive shifts in the conductance versus voltage curve
(McCormack et al., 1991; Bezanilla, 2000). These conduc-
tance shifts suggest that the S4 heptad repeat might be
critical for the tight coupling that exists in voltage-gated
channels between movements of the voltage sensor and the
opening of the pore. Perhaps the heptad repeat in the
carboxyl terminus of the b subunit could affect the coupling
between charge movements in the DHPR voltage sensor and
opening of the RYR1 channel. It is also conceivable that the
heptad repeat in D5 could interact with a second heptad
repeat present in domain D2 of b1a, namely L149(n)-
V(nþ7)-V(nþ14)-L(nþ21). This is an interesting possibility
because the heptad repeat in D2 is conserved among b
subunits, whereas the repeat in D5 is only present in b1a.
The voltage dependent coupling mediated by b1a could thus
arise from a speciﬁc protein folding governed by these two
heptad repeats.
One of the important conclusions of the present work is
that a DHPR complex with a b subunit having an intact
carboxyl terminus is essential for fast skeletal-type EC
coupling. Thus we would speculate that molecular determi-
nants in the b subunit are either essential for the physical
docking between DHPR tetrads and the tetrameric RyR1
complex or play a critical role in the transmission of the
EC coupling signal. However, it must be realized that in
closely interacting protein complexes, such as the DHPR and
RyR1, these two possibilities are not mutually exclusive
(Franzini-Armstrong and Protasi, 1997). As a function of
the truncation length, we observed a progressive loss of
voltage-dependent EC coupling and the emergence of Ca2þ-
dependent EC coupling. Furthermore, for moderate trunca-
tions such as D7 and D21, Ca2þ transients were independent
of external Ca2þ (Fig. 8). However, the amplitudes of the
Ca2þ transients expressed by these two variants were larger
with the 200-ms than with the 50-ms depolarizations (Fig. 7).
These results are inherently difﬁcult to explain within the
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conceptual framework described for EC coupling in skeletal
and cardiac cells because pulse length dependence is not an
obvious feature of skeletal-type EC coupling and Ca2þ
currents had no obvious effects in myotubes expressing D7
and D21. The intermediate form of EC coupling favored by
D7 and D21, as well as the fully ﬂedged Ca2þ-dependent
mechanism observed for the more severe truncations, could
originate from a progressive weakening of physical docking
of the DHPR and RyR1 complexes brought about by a DHPR
with a progressively truncated b subunit. The intermediate
EC coupling mechanism favored by D7 and D21 might thus
result from the transmission of a voltage signal to RyR1 that
is kinetically impaired such that a long stimulus may be
necessary to open a signiﬁcant number of RyR1 channels.
This explanation is directly supported by the progressively
slower rate of increase of the ﬂuorescence signal observed as
a function of b truncation length (Fig. 9 B). A slow voltage
dependent activation of RyR1 channels could account for the
sigmoidal voltage dependence of Ca2þ transients and the
higher DF/F max observed with the longer depolarization
observed in myotubes expressing D7 and D21. Clearly,
a study of the kinetics of charge movements expressed by D7
and D21 should shed light on this explanation. Ca2þ-
dependent EC coupling favored by the more severely
truncated D29 and D60 variants might result from the
transmission of a voltage signal to RyR1 that is unable to
open a signiﬁcant number of RyR1 channels due to a severe
undocking of the DHPR and RyR1 complexes. Those RyR1
channels not activated by voltage might thus be available for
activation by the Ca2þ current. It is also possible that the
partial elimination of the carboxyl terminus of the b subunit
leads somehow to an increase in the Ca2þ sensitivity of
RyR1 and that the stronger Ca2þ transients seen with the
200-ms depolarization were due to excessive Ca2þ feedback
on RyR1. Interestingly, spontaneous Ca2þ sparks in b1 KO
myotubes were found to be signiﬁcantly wider and longer in
duration than their counterparts in normal or dysgenic (a1S
null) myotubes (Conklin et al., 1999). Thus, the properties of
clusters of RyR1 channels can be modiﬁed by the absence of
the b subunit. Finally, there is an alternative explanation to
consider brought about by the study of Simon and Hill
(1992), demonstrating that voltage activation of four DHPR
voltage sensors, presumably one in each DHPR in the tetrad,
is required for activation of SR Ca2þ release. Truncated b
subunits in each DHPR could disrupt the voltage-sensing
activity within the tetrad or disrupt the DHPR tetrad
arrangement altogether. In principle, tetrad disruption could
account for the slow rate of SR Ca2þ release observed in
the present experiments hence, this remains as an attractive
possibility. These three mechanisms of EC coupling dis-
ruption by truncated b subunits, namely a slowing in the
transmission of the voltage signal from the DHPR to RyRl,
an increase in RyR1 Ca2þ sensitivity, and/or a disruption
of the DHPR tetrad arrangement, deserves close scrutiny in
future experiments.
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